Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving antigen-antibody binding – specific binding protein...
Reexamination Certificate
2003-03-28
2010-02-23
Landsman, Robert (Department: 1647)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving antigen-antibody binding, specific binding protein...
C435S069100, C435S348000, C435S456000, C530S350000, C536S023500
Reexamination Certificate
active
07666610
ABSTRACT:
Methods for measuring transporter activity using budding baculoviruses that do not express endogenous transporters on their envelope have a low background level and can measure the target activity with a high sensitivity. Such methods can be used to measure functional changes due to transporter SNPs over a more extensive range of substrates, and can be applied to tailor-made therapies.
REFERENCES:
patent: 5500346 (1996-03-01), Bright et al.
patent: 5849525 (1998-12-01), Hediger
patent: 6270978 (2001-08-01), Bright et al.
patent: 6713278 (2004-03-01), Bouvier et al.
patent: 2005/0004227 (2005-01-01), Saitoh
patent: 2005/0222391 (2005-10-01), Kodama et al.
patent: 2005/0281825 (2005-12-01), Kodama et al.
patent: 2006/0084119 (2006-04-01), Saitoh et al.
patent: 2006/0210569 (2006-09-01), Kodama et al.
patent: 2008/0040820 (2008-02-01), Kodama et al.
patent: 9676557 (1997-06-01), None
patent: 1142473 (2001-10-01), None
patent: 1 731 032 (2006-12-01), None
patent: 6-261761 (1994-09-01), None
patent: 8-134100 (1996-05-01), None
patent: 11-172 (1999-01-01), None
patent: 2001-197846 (2001-07-01), None
patent: 2001-139496 (2005-05-01), None
patent: 99071666 (1999-09-01), None
patent: WO 97/19919 (1997-06-01), None
patent: WO 98/46777 (1998-10-01), None
patent: WO 00/28016 (2000-05-01), None
patent: WO 03/033024 (2003-04-01), None
patent: WO 03/047621 (2003-06-01), None
patent: WO 03/083116 (2003-10-01), None
patent: WO 03/104453 (2003-12-01), None
Hsu et al., Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction, 1998, Pharmaceutical Research, vol. 15, No. 9, pp. 1376-1381.
Garcia et al., cDNA cloning of MCT2, a second monocarboxylate transporter expressed in different cells than MCT1, 1995, Journal of Biological Chemistry, vol. 270, No. 4, pp. 1843-1849.
Miyasaka, et al., Characterization of human taurine transporter expressed in insect cells using recombinant baculovirus, 2001, Protein Expression and Purification, vol. 23, pp. 389-397.
Hsu et al., Overexpression of human intestinal oligopeptide transporter in mammalian cells via adenoviral transduction, 1998, Pharmaceutical Research, vol. 15, No. 9, pp. 1376-1381.
ATCC Web Catalog, “Tumor Cell Lines” www.atcc.org (2007), 15 pages.
Boublik et al., “Eukaryotic Virus Display: Engineering the major Surface Glycoprotein of theAutographa californicaNuclear Polyhedrosis Virus (ScNPV) for the Presentation of Foreign Proteins on the Virus Surface,”Biotechnology, 13 1079-1084 (1995).
“Cancer Classification,” SEER Training Website, www.training.seer.cancer.gov/module—cancer—disease/unti3-categories2—by—histology (2005), 3 pages.
Grever et al., “The National Cancer Institute: Cancer Drug Discovery and Development Program,” Seminars in Oncology, 19(6): 622-638 (1992).
Hefferon et al., “Host Cell receptor Binding by Baculovirus GP64 and Kinetics of Virion Entry,”Virology, 258: 455-468 (1999).
Kamada et al., “Production of GP64, the Major Envelope Glycoprotein of Budded Baculovirus, Transgenic Mice and Induction of immunological Tolerance of GP64 Transgenic Mice,”Nihon Bunshi Seibutsu Gakkai Nenkai Program Koen Yoshishu, 26: 659 (2003) (Translation Provided).
Lu et al., “Characterization of a Truncated Soluble Form of the Baculovirus (AcMNPV) Major Envelope Protein Gp64,”Protein Expression and Purification, 24: 196-201 (2002).
Monsma et al., “Identification of a Membrane Fusion Domain and an Oligomerization Domain in the Baculovirus GP64 Envelope Fusion Protein,”Journal of Virology, 69: 2583-2595 (1995).
Monsma et al., “The GP64 Envelope Fusion Protein is an Essential Baculovirus Protein Required for Cell-to-Cell Transmission of Infection,”Journal of Virology, 70: 4607-4616 (1996).
Ohtomo et al., “Generation of Anti-Human CCR Antagonistic Antibodies in GP64 Expressing and CCR2-Deficient Mice Using CCR2 Expressed Budded Baculovirus as an Antigen,”Nihon Bunshi Seibutsu Gakkai Nenkai Program Koen Yoshishu, 26: 660 (2003) (Translation Provided).
Seliger et al., “Analysis of the MHC Class I Antigen Presentation Machinery in Human Embryonal Carcinomas: Evidence for Deficiencies in TAP, LMP, and MHC Class I Expression and Their Upregulation by IFN-γ,” Scandinavian Journal of Immunology, 46: 625-632 (1997) (Abstract).
Suzuki et al., “Effects of Retinoic Acid on Lung Smooth Muscle Cells,” Meeting on Experimental Biology: Translating The Genome (Apr. 17-21, 2004) as published in FASEB Journal, 18(4-5): 355-356 (2004) (Abstract).
Tamura et al.,“CD14 Transgenic Mice Expressing Membrane and Soluble Forms: Comparisons of Levels of Sytokines and Lethalities in Response to Lipopolysaccharide Between Transgenic and Non-Transgenic Mice,”International Immunology, 11:333-339 (1999).
Watanabe et al., “Enhances Immune Responses in Transgenic Mice Expressing a Truncated Form of the Lymphocyte Semaphorin CD1001,”J. Immunol. 167: 4321-4328 (2001).
Braunagel et al., “Autographe californica Nuclear Polyhedrosis Virus, PDV, and ECV Viral Envelopes and Nucleocapsids: Structural Proteins, Antigens, Lipid and Fatty Acid Profiles”, Virology, vol. 202, pp. 315-320 (1994).
Grabherr et al., “Developments in the use of baculoviruses for the surface display of complex eukaryotic proteins”, Trends in Biology, vol. 19(6), pp. 231-235 (2001).
Marheineke et al., “Lipid composition ofSpodoptera frugiperda(Sf9) andTrichoplusia ni(Tn) insect cells used for baculovirus infection”, FEBS vol. 441, pp. 49-52 (1998).
Zhou X. et al., “Characterization of an oligopeptide transporter in renal lysosomes”, Biochim Biophys Acta, vol. 1466(1-2), pp. 372-378 (2000).
Lee VHL et al., “Biopharmaceutics of transmucosal peptide and protein drug administration: role of transport mechanisms with a focus on the involvement of PepT1”, J. Control Release, vol. 62(1-2), pp. 129-140 (1999).
Loisel TP et al., “Recovery of homogeneous and functional β2-adrenergic receptors from extracellular baculovirus particles”, Nat Biotechnol, vol. 15(12), pp. 1300-1304 (1997).
Mangor JT et al., “A GP64-Null Baculovirus Pseudotyped with Vesicular Stomatitis Virus G Protein”, Journal of Virology, vol. 75(6), pp. 2544-2556 (2001).
Szakács G et al., “Characterization of the ATPase Cycle of Human ABCA1: Implications for Its Function as a Regulator Rather Than an Active Transporter”, Biochem Biophys Res Commun, vol. 288(5), pp. 1258-1264 (2001).
Noe J et al., “Characterization of the Mouse Bile Salt Export Pump Overexpressed in the Baculovirus System”, Hepatology, vol. 33(5), pp. 1223-1231 (2001).
Sakaguchi T. et al., “The Ion Channel Activity of the Influenza Virus M2 Protein Affects Transport through the Golgi Apparatus”, J Cell Biol., vol. 133(4), pp. 733-747 (1996).
Mikhailov MV et al., “Expression of functionally active ATP-sensitive K-channels in insect cells using baculovirus”, FEBS Lett, vol. 429(3), pp. 390-394 (1998).
Strehlow D. et al., “Retroviral membrane display of apoptotic effector molecules”, Proc Natl Acad Sci USA, vol. 97(8), pp. 4209-4214 (2000).
Sun D. et al., “Drug Inhibition of Gly-Sar Uptake and hPepT1 Localization using hPepT1-GFP Fusion Protein”, AAPS PharmSci., vol. 3(1), pp. 1-9 (2001).
Sai Y. et al., “Immunolocalization and pharmacological relevance of oligopeptide transporter PepT1 in intestinal absorption of β-lactam antibiotics”, FEBS Lett, vol. 392(1), pp. 25-29 (1996).
Basu SK et al., “Development and Utility of Anti-PepT1 Anti-Peptide Polyclonal Antibodies”, Pharmaceutical Research, vol. 15(2), pp. 338-342 (1998).
Gonzalez DE et al., “An Olgiopeptide Transporter Is Expressed at High Levels in the Pancreatic Carcinona Cell Lines AsPc-1 and Capan-2I”, Cancer Res., vol. 58(3), pp. 519-525
Ohtomo Toshihiko
Saitoh Ryoichi
Tsuchiya Masayuki
Chugai Seiyaku Kabushiki Kaisha
Dang Ian
Fish & Richardson P.C.
Landsman Robert
LandOfFree
Expressing transporters on viral envelopes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Expressing transporters on viral envelopes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Expressing transporters on viral envelopes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4235275